Full Prescribing Information, Including BOXED WARNING
Read About Twirla
Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022
Agile Therapeutics Updates Second Quarter 2022 Guidance
Agile Therapeutics to Participate in Maxim Group’s Upcoming Women’s Health Panel
Agile Therapeutics Announces Closing of $24 Million Upsized Public Offering
Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering
Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
Our pipeline reflects our commitment to bringing women the healthcare choices they deserve. All current Agile Therapeutics product and product candidates use our proprietary Skinfusion® Technology.
Commitment. Passion. Drive.
These are the qualities that make us who we are, from the top down.
©2021 Agile Therapeutics®. All Rights Reserved.
View a snapshot of our consumer advertising